Title: Severe Respiratory Depression Following Talwin
Abstract: Severe respiratory depression occurred in a 41-year-old woman with underlying respiratory insufficiency, after she received 30 mg of pentazocine (Talwin®) intramuscularly. This drug can cause significant respiratory depression and should be used with the same precautions as narcotics in patients with limited respiratory reserve.
Publication Year: 2015
Publication Date: 2015-05-14
Language: en
Type: article
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot